CHONGQING LUMMY PHARMACEUTICAL CO., LTD.

Highlights Chongqing Lummy Pharmaceutical Co., Ltd.

Equities

300006

CNE100000H10

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 16/07/2024 am IST			5-day change	1st Jan Change
2.33 ^CNY	-0.43%		0.00%	-37.37%

05/06	Lummy Pharmaceutical Gets Nod to Market Naloxone Hydrochloride Injection	MT
23/04	Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lummy Pharmaceutical Gets Nod to Market Naloxone Hydrochloride Injection	05/06	MT
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04	CI
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03	CI
Lummy Pharma Gets Nod to Raise Dosage of Gastric Drug	18/03	MT
Lummy Pharma Gets Nod to Market Nicorandil	04/03	MT
Lummy Pharmaceutical's Ramosetron Hydrochloride Injection Passes Regulatory Evaluation	10/11	MT
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	20/23/20	CI
Lummy Pharmaceutical's Unit Gets Nod to Trial Ovarian Cancer Drug; Shares Surge 20%	15/23/15	MT
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23/23/23	CI
Chongqing Lummy Pharmaceutical's Cancer Drug Passes Regulatory Evaluation	07/23/07	MT
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	21/23/21	CI
Lummy Pharma Unit Gets Regulatory Nod in China for Liver Cirrhosis Drug	02/23/02	MT
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25	CI
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/22/26	CI
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25	CI
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/21/28	CI
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	30/21/30	CI
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	23/21/23	CI
Chongqing Lummy Pharmaceutical Co., Ltd. Announces Cash Dividend for the Year 2020	22/21/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Chongqing Lummy Pharmaceutical Co., Ltd.

Equities

300006

CNE100000H10

Highlights

Filters